December 16th, 2011 at 10:11 am (ADHD In The News)
HOT OFF THE PRESS…
After nearly 10 months, the nationwide shortage of ADHD drugs has taken a toll on people’s lives across the nation. The shortage has effected school performance, work performance, relationships and more.
The issue drew renewed attention Thursday, when the White House issued an interim rule that requires drugmakers that are the only producers of certain critical medications to report to the Food and Drug Administration all manufacturing interruptions that could disrupt supplies.
READ FULL STORY
Comments
December 5th, 2011 at 10:01 pm (ADHD In The News)
Four gene variants, all members of the glutamate receptor gene family, appear to be involved in vital brain signaling pathways in a sub-set of children with ADHD (attention deficit hyperactivity disorder), researchers from the Center for Applied Genomics at The Children’s Hospital of Philadelphia reported in the journal Nature Genetics. The authors add that their findings could help create drugs that target those pathways, offering potential therapies for ADHD patients with those specific gene variants. There are an estimated half-a-million American children with ADHD and these gene variants.
Study leader Hakon Hakonarson, M.D., Ph.D., said:
“At least 10 percent of the ADHD patients in our sample have these particular genetic variants. The genes involved affect neurotransmitter systems in the brain that have been implicated in ADHD, and we now have a genetic explanation for this link that applies to a subset of children with the disorder.”
** READ FULL ARTICLE **
Comments
